Damon Runyon Cancer Research Foundation
@damonrunyon.org
Funding brave and bold since 1946.
damonrunyon.org
damonrunyon.org
A study from Damon Runyon scientists Eirini Papapetrou, MD, PhD, Piro Lito, MD, PhD, Elli Papaemmanuil, PhD, and Elvin Wagenblast, PhD, explains why RAS-mutant leukemias behave differently, and may offer a clue to overcoming their treatment resistance. Read more: https://bit.ly/4p61B6k
A step toward overcoming treatment resistance in leukemia | New Discoveries
Since the Food and Drug Administration approved the targeted therapy drug venetoclax in 2020, it has become a first-line treatment for acute myeloid leukemia (AML), a blood cancer. Unfortunately, some...
bit.ly
November 14, 2025 at 8:55 PM
A study from Damon Runyon scientists Eirini Papapetrou, MD, PhD, Piro Lito, MD, PhD, Elli Papaemmanuil, PhD, and Elvin Wagenblast, PhD, explains why RAS-mutant leukemias behave differently, and may offer a clue to overcoming their treatment resistance. Read more: https://bit.ly/4p61B6k
Earlier this month, we proudly welcomed the newest cohort of Damon Runyon Fellows! These 16 brilliant postdocs will receive four years of independent funding to advance their investigation of causes, treatments, and prevention strategies for all types of cancer. Read more: https://bit.ly/4nc25Hq
September 19, 2025 at 4:54 PM
Earlier this month, we proudly welcomed the newest cohort of Damon Runyon Fellows! These 16 brilliant postdocs will receive four years of independent funding to advance their investigation of causes, treatments, and prevention strategies for all types of cancer. Read more: https://bit.ly/4nc25Hq
The recipient of the 2025 Damon Runyon-Jake Wetchler Award for Pediatric Innovation, recognizing work with great potential to impact pediatric cancers, is Pu Zheng, PhD, a Damon Runyon-Fayez Sarofim Fellow working on new technologies to visualize cancer cell behavior within its native environment.
September 19, 2025 at 3:24 PM
The recipient of the 2025 Damon Runyon-Jake Wetchler Award for Pediatric Innovation, recognizing work with great potential to impact pediatric cancers, is Pu Zheng, PhD, a Damon Runyon-Fayez Sarofim Fellow working on new technologies to visualize cancer cell behavior within its native environment.
Reposted by Damon Runyon Cancer Research Foundation
Wanted to give a proper shout-out to @txrwang.bsky.social for earning a @damonrunyon.org QBio Fellowship! He is a perfect example of the next gen of scientists who think deeply and creatively across disciplines of biology and ML/AI. I learned a lot from him. www.damonrunyon.org/news/entries... 1/2
Damon Runyon Cancer Research Foundation awards Quantitative Biology Fellowships to five cutting-edge scientists
www.damonrunyon.org
July 23, 2025 at 8:47 PM
Wanted to give a proper shout-out to @txrwang.bsky.social for earning a @damonrunyon.org QBio Fellowship! He is a perfect example of the next gen of scientists who think deeply and creatively across disciplines of biology and ML/AI. I learned a lot from him. www.damonrunyon.org/news/entries... 1/2
Reposted by Damon Runyon Cancer Research Foundation
Creative Ways to Back Young Scientists. Listen to Yung Lie and Andy Rachleff of Damon Runyon Cancer Research Foundation on The Long Run podcast. timmermanreport.com/2025/07/crea...
Creative Ways to Back Young Scientists: Andy Rachleff and Yung Lie on The Long Run - TimmermanReport.com
Yung Lie and Andy Rachleff are today’s guests on The Long Run. Yung is the president and CEO of the Damon Runyon Cancer Research Foundation, based in New York. Andy is the board chair. Andy was one of...
timmermanreport.com
July 23, 2025 at 1:40 PM
Creative Ways to Back Young Scientists. Listen to Yung Lie and Andy Rachleff of Damon Runyon Cancer Research Foundation on The Long Run podcast. timmermanreport.com/2025/07/crea...
Damon Runyon mentor-mentee duo Piro Lito, MD, PhD, and Antonio Cuevas-Navarro, PhD, have developed a new approach to treating RAS-driven cancers, such as colorectal and pancreatic. Rather than inhibiting the cancerous protein, their drug restores its natural function. Read more:
New Discoveries and Honors in Cancer Research | Damon Runyon
www.damonrunyon.org
July 23, 2025 at 1:49 PM
Damon Runyon mentor-mentee duo Piro Lito, MD, PhD, and Antonio Cuevas-Navarro, PhD, have developed a new approach to treating RAS-driven cancers, such as colorectal and pancreatic. Rather than inhibiting the cancerous protein, their drug restores its natural function. Read more:
Reposted by Damon Runyon Cancer Research Foundation
The Clinical Investigator Award program was designed to increase the number of physician-scientists capable of translating discoveries in the lab into new treatments for cancer patients.
@tanaya-shree.bsky.social was recognized as one of five new @damonrunyon.org Clinical Investigators in 2025.
@tanaya-shree.bsky.social was recognized as one of five new @damonrunyon.org Clinical Investigators in 2025.
July 21, 2025 at 3:18 PM
The Clinical Investigator Award program was designed to increase the number of physician-scientists capable of translating discoveries in the lab into new treatments for cancer patients.
@tanaya-shree.bsky.social was recognized as one of five new @damonrunyon.org Clinical Investigators in 2025.
@tanaya-shree.bsky.social was recognized as one of five new @damonrunyon.org Clinical Investigators in 2025.
Reposted by Damon Runyon Cancer Research Foundation
Congratulations to Dr. Tanaya Shree on receiving the 2025 @damonrunyon.org Clinical Investigator Award!
The recipients of this award are outstanding, early-career physician-scientists conducting patient-oriented cancer research under the mentorship of the nation's leading scientists and clinicians.
The recipients of this award are outstanding, early-career physician-scientists conducting patient-oriented cancer research under the mentorship of the nation's leading scientists and clinicians.
July 21, 2025 at 3:18 PM
Congratulations to Dr. Tanaya Shree on receiving the 2025 @damonrunyon.org Clinical Investigator Award!
The recipients of this award are outstanding, early-career physician-scientists conducting patient-oriented cancer research under the mentorship of the nation's leading scientists and clinicians.
The recipients of this award are outstanding, early-career physician-scientists conducting patient-oriented cancer research under the mentorship of the nation's leading scientists and clinicians.
Reposted by Damon Runyon Cancer Research Foundation
Honored to be selected as a Damon Runyon Clinical Investigator among this group of incredible scientists and appreciative of the support to conduct patient-centered mechanistic research. @ohsunews.bsky.social @ohsuknight.bsky.social #CancerImmunotherapy #LymphomaResearch
Congratulations to the newest Damon Runyon Clinical Investigators! The five recipients of this prestigious award are exceptional early-career physician-scientists conducting patient-centered cancer research.
July 16, 2025 at 6:15 AM
Honored to be selected as a Damon Runyon Clinical Investigator among this group of incredible scientists and appreciative of the support to conduct patient-centered mechanistic research. @ohsunews.bsky.social @ohsuknight.bsky.social #CancerImmunotherapy #LymphomaResearch
Congratulations to the newest Damon Runyon Clinical Investigators! The five recipients of this prestigious award are exceptional early-career physician-scientists conducting patient-centered cancer research.
July 15, 2025 at 3:16 PM
Congratulations to the newest Damon Runyon Clinical Investigators! The five recipients of this prestigious award are exceptional early-career physician-scientists conducting patient-centered cancer research.
Reposted by Damon Runyon Cancer Research Foundation
Out now:
rdcu.be/evxCv
We've used CoQ10 headgroup intermediates to treat mouse models of a mitochondrial disease and improve the neurological symptoms of a patient with this disease.
Grateful for funding from @damonrunyon.org , Pershing Square Foundation, @americancancersoc.bsky.social, NIH!
rdcu.be/evxCv
We've used CoQ10 headgroup intermediates to treat mouse models of a mitochondrial disease and improve the neurological symptoms of a patient with this disease.
Grateful for funding from @damonrunyon.org , Pershing Square Foundation, @americancancersoc.bsky.social, NIH!
Coenzyme Q headgroup intermediates can ameliorate a mitochondrial encephalopathy - Nature
Decreased brain coenzyme Q10 levels cause encephalopathy and are associated with neurodegeneration; supplementation with 4-HMA or 4-HB restores coenzyme Q10 synthesis in mice and humans with HPDL vari...
www.nature.com
July 9, 2025 at 5:32 PM
Out now:
rdcu.be/evxCv
We've used CoQ10 headgroup intermediates to treat mouse models of a mitochondrial disease and improve the neurological symptoms of a patient with this disease.
Grateful for funding from @damonrunyon.org , Pershing Square Foundation, @americancancersoc.bsky.social, NIH!
rdcu.be/evxCv
We've used CoQ10 headgroup intermediates to treat mouse models of a mitochondrial disease and improve the neurological symptoms of a patient with this disease.
Grateful for funding from @damonrunyon.org , Pershing Square Foundation, @americancancersoc.bsky.social, NIH!
Reposted by Damon Runyon Cancer Research Foundation
Join me at 3 pm Mon. June 16 at the BIO International Convention's Storytelling Stage to hear about the past, present, and future of Timmerman Traverse for @lifesciencecares.bsky.social @damonrunyon.org convention.bio.org/program/bio-...
BIO International Convention | Storytelling Stage
Experience powerful stories from researchers, patients, and innovators at the BIO 2025 Storytelling Stage, June 16–19 in Boston.
convention.bio.org
June 10, 2025 at 11:08 PM
Join me at 3 pm Mon. June 16 at the BIO International Convention's Storytelling Stage to hear about the past, present, and future of Timmerman Traverse for @lifesciencecares.bsky.social @damonrunyon.org convention.bio.org/program/bio-...
Reposted by Damon Runyon Cancer Research Foundation
🎉 Congratulations to #MSKPostdoc Paul Klauser (@paulklauser.bsky.social), mentored by @lewislabmskcc.bsky.social & @caleblareau.bsky.social, on being awarded the prestigious Damon Runyon Quantitative Biology Fellowship! 👏
Congratulations to the newest Damon Runyon Quantitative Biology Fellows, five exceptional early-career scientists who are using state-of-the-art computational tools to bring cancer biology into high resolution!
June 5, 2025 at 3:50 PM
🎉 Congratulations to #MSKPostdoc Paul Klauser (@paulklauser.bsky.social), mentored by @lewislabmskcc.bsky.social & @caleblareau.bsky.social, on being awarded the prestigious Damon Runyon Quantitative Biology Fellowship! 👏
Reposted by Damon Runyon Cancer Research Foundation
Congrats to IICD postdoc Aaron Zweig (@elhamazizi.bsky.social and @davidaknowles.bsky.social groups), awarded the prestigious Damon Runyon Quantitative Biology Fellowship @damonrunyon.org—one of only five granted this year! 🔗 bit.ly/3TeK7GQ #CancerResearch #QuantBio
June 5, 2025 at 4:20 PM
Congrats to IICD postdoc Aaron Zweig (@elhamazizi.bsky.social and @davidaknowles.bsky.social groups), awarded the prestigious Damon Runyon Quantitative Biology Fellowship @damonrunyon.org—one of only five granted this year! 🔗 bit.ly/3TeK7GQ #CancerResearch #QuantBio
Congratulations to the newest Damon Runyon Quantitative Biology Fellows, five exceptional early-career scientists who are using state-of-the-art computational tools to bring cancer biology into high resolution!
June 4, 2025 at 7:57 PM
Congratulations to the newest Damon Runyon Quantitative Biology Fellows, five exceptional early-career scientists who are using state-of-the-art computational tools to bring cancer biology into high resolution!
Starting now!
We had more donations overnight, meaning #ArvCon2025 is just shy of $4k raised for @damonrunyon.org! Join us at 3 p.m. EDT for the 4th and final day of our charity event, featuring DRCRF scientists, Daggerheart, and GM @mikerunderwood.bsky.social, as we head for our $5k goal! twitch.tv/arvaneleron
May 26, 2025 at 7:04 PM
Starting now!
Reposted by Damon Runyon Cancer Research Foundation
Now up to almost $1700 raised for @damonrunyon.org during Day Two of #ArvCon2025, join us at 5:15 p.m. EDT for the next TTRPG session with the Expedition from the Mysterious Peaks crew! www.twitch.tv/arvaneleron
May 24, 2025 at 9:01 PM
Now up to almost $1700 raised for @damonrunyon.org during Day Two of #ArvCon2025, join us at 5:15 p.m. EDT for the next TTRPG session with the Expedition from the Mysterious Peaks crew! www.twitch.tv/arvaneleron
Reposted by Damon Runyon Cancer Research Foundation
And the day has arrived! Tonight at 9 p.m. EDT, please join us for Day One of #ArvCon2025 to benefit @damonrunyon.org, featuring a TTRPG one-shot with the amazing Arvocalists!
#ArvCon2025 to benefit @damonrunyon.org is less than a week away, and I'm excited and honored to announce our sponsors and our schedule! Please spread the word and share widely, as we aim to make our eleventh annual ArvCon the best one yet! 1/?
May 23, 2025 at 3:24 PM
And the day has arrived! Tonight at 9 p.m. EDT, please join us for Day One of #ArvCon2025 to benefit @damonrunyon.org, featuring a TTRPG one-shot with the amazing Arvocalists!
Coming up this weekend - it's going to be a good one!
#ArvCon2025 to benefit @damonrunyon.org is less than a week away, and I'm excited and honored to announce our sponsors and our schedule! Please spread the word and share widely, as we aim to make our eleventh annual ArvCon the best one yet! 1/?
May 20, 2025 at 5:35 PM
Coming up this weekend - it's going to be a good one!
Reposted by Damon Runyon Cancer Research Foundation
We all made it! The Timmerman Traverse for Damon Runyon Cancer Research Foundation team arrived at Everest Base Camp (elev. 17,600 feet) on Apr. 23, 2025. Another awe-inspiring day in the mountains, supporting brave and bold cancer research. Thanks to all who supported this marvelous experience.
April 24, 2025 at 11:11 AM
We all made it! The Timmerman Traverse for Damon Runyon Cancer Research Foundation team arrived at Everest Base Camp (elev. 17,600 feet) on Apr. 23, 2025. Another awe-inspiring day in the mountains, supporting brave and bold cancer research. Thanks to all who supported this marvelous experience.
Reposted by Damon Runyon Cancer Research Foundation
Day 5 - Trek to Dengboche with incredible views of Mt. Everest with the Timmerman Traverse for @damonrunyon.org team!
April 20, 2025 at 2:35 AM
Day 5 - Trek to Dengboche with incredible views of Mt. Everest with the Timmerman Traverse for @damonrunyon.org team!
Reposted by Damon Runyon Cancer Research Foundation
Timmerman Traverse for @damonrunyon.org. Trekking to Everest Base Camp with our first sight of the top of the world today in Syangboche! Absolutely epic!
April 17, 2025 at 4:53 AM
Timmerman Traverse for @damonrunyon.org. Trekking to Everest Base Camp with our first sight of the top of the world today in Syangboche! Absolutely epic!
After testing 1.2 billion (yes - with a b!) drug candidates, Damon Runyon Fellow Fangyu Liu, PhD, and her colleagues may have discovered a safer way to target CaSR, a protein that has been implicated in several cancers. Read more: www.damonrunyon.org/our-impact/n...
March 20, 2025 at 2:30 PM
After testing 1.2 billion (yes - with a b!) drug candidates, Damon Runyon Fellow Fangyu Liu, PhD, and her colleagues may have discovered a safer way to target CaSR, a protein that has been implicated in several cancers. Read more: www.damonrunyon.org/our-impact/n...
Exciting work from former Damon Runyon Fellow and 2022 Damon Runyon-Jake Wetchler Award for Pediatric Innovation winner @anandpatellab.bsky.social 👇 bsky.app/profile/stju...
Researchers at St. Jude are pioneering the use of 3D printing to advance pediatric cancer research. @anandpatellab.bsky.social and his team are creating 3D tumor models that mimic the microenvironment of rhabdomyosarcoma (RMS), a rare and aggressive cancer.
March 20, 2025 at 2:28 PM
Exciting work from former Damon Runyon Fellow and 2022 Damon Runyon-Jake Wetchler Award for Pediatric Innovation winner @anandpatellab.bsky.social 👇 bsky.app/profile/stju...
Reposted by Damon Runyon Cancer Research Foundation
We are delighted to announce our most recent class of Damon Runyon Fellows! These 13 scientists will receive four years of independent funding to investigate cancer causes, mechanisms, therapies, and prevention. Read more: www.damonrunyon.org/news/entries...
March 10, 2025 at 12:54 AM